Jason Roszik Selected Research

Jason Roszik Research Topics

Disease

115	Neoplasms (Cancer) 01/2024 - 02/2013
41	Melanoma (Melanoma, Malignant) 12/2023 - 09/2015
14	Lung Neoplasms (Lung Cancer) 12/2022 - 10/2016
9	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2017
7	Neoplasm Metastasis (Metastasis) 01/2024 - 11/2020
7	Adenocarcinoma 01/2022 - 10/2016
6	Carcinogenesis 10/2021 - 05/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2018
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2018
4	Carcinoma (Carcinomatosis) 01/2021 - 01/2018
3	Leiomyosarcoma 12/2023 - 01/2017
3	Synovial Sarcoma (Synovioma) 01/2022 - 01/2017
3	Aneuploidy (Aneuploid) 01/2021 - 01/2018
3	Disease Progression 01/2017 - 05/2016
2	Breast Neoplasms (Breast Cancer) 01/2024 - 12/2023
2	Diarrhea 12/2023 - 01/2017
2	Fatigue 12/2023 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2017
2	Osteosarcoma (Osteogenic Sarcoma) 10/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2017
2	Uveal melanoma 11/2020 - 10/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 01/2017
2	Polyploidy 10/2019 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 09/2019 - 01/2019
2	Testicular Neoplasms (Testicular Cancer) 05/2019 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2017
2	Hypoxia (Hypoxemia) 01/2018 - 10/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 01/2017
1	Endometrial Neoplasms (Endometrial Cancer) 02/2024
1	Acidosis 12/2023
1	Hyperglycemia 12/2023
1	Hypertriglyceridemia 12/2023

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2016
15	AntigensIBA 01/2024 - 02/2013
12	Immune Checkpoint InhibitorsIBA 01/2023 - 02/2016
12	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
10	Peptides (Polypeptides)IBA 01/2024 - 01/2017
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 09/2015
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2015
6	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2017
6	Messenger RNA (mRNA)IBA 09/2019 - 01/2016
5	CytokinesIBA 01/2022 - 02/2016
4	VemurafenibIBA 02/2023 - 10/2016
4	EpitopesIBA 07/2022 - 01/2017
4	InterferonsIBA 01/2022 - 01/2017
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2018
4	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2023 - 01/2016
3	Carboplatin (JM8)FDA LinkGeneric 04/2023 - 01/2016
3	Everolimus FDA Link 02/2023 - 11/2017
3	trametinibIBA 01/2023 - 08/2016
3	Macrophage Migration-Inhibitory FactorsIBA 05/2022 - 12/2020
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 01/2017
3	HLA-A Antigens (HLA-A)IBA 10/2020 - 01/2017
3	VaccinesIBA 01/2018 - 10/2017
3	IpilimumabIBA 01/2017 - 10/2016
2	Therapeutic UsesIBA 01/2024 - 01/2019
2	sapanisertibIBA 12/2023 - 04/2023
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2023 - 04/2023
2	Indicators and Reagents (Reagents)IBA 12/2023 - 09/2019
2	Sorafenib (BAY 43-9006)FDA Link 02/2023 - 01/2016
2	EnzymesIBA 01/2023 - 01/2020
2	Prostaglandin-E SynthasesIBA 01/2023 - 01/2019
2	Dinoprostone (PGE2)FDA Link 01/2023 - 05/2016
2	Small Interfering RNA (siRNA)IBA 12/2022 - 06/2016
2	Ubiquitin-Specific ProteasesIBA 12/2022 - 01/2021
2	Immune Checkpoint ProteinsIBA 01/2022 - 01/2018
2	GenieIBA 01/2022 - 08/2019
2	Circulating Tumor DNAIBA 01/2022 - 01/2021
2	pralsetinibIBA 10/2021 - 10/2020
2	Chimeric Antigen ReceptorsIBA 10/2021 - 07/2014
2	selpercatinibIBA 10/2021 - 10/2020
2	Interleukin-12 (IL 12)IBA 01/2021 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 12/2017
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2021 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2017
2	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2021 - 01/2017
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021 - 12/2020
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2020 - 01/2018
2	Histones (Histone)IBA 01/2020 - 01/2017
2	Long Noncoding RNAIBA 01/2019 - 06/2016
2	CitrullineIBA 01/2019 - 01/2018
2	B7-H1 AntigenIBA 01/2018 - 01/2018
2	LigandsIBA 01/2018 - 09/2015
2	UbiquitinIBA 01/2018 - 01/2017
2	pazopanib FDA Link 11/2017 - 01/2017
2	Histocompatibility Antigens Class IIBA 01/2017 - 05/2016
2	Cathepsin GIBA 01/2017 - 01/2017
1	ONC212IBA 01/2024
1	TIC10 compoundIBA 01/2024
1	Estrogen ReceptorsIBA 01/2024
1	Estrogen Receptor alphaIBA 01/2024
1	CreatinineIBA 12/2023

Therapy/Procedure

59	Therapeutics 01/2024 - 01/2016
35	Immunotherapy 01/2024 - 02/2013
5	Drug Therapy (Chemotherapy) 02/2023 - 01/2017
3	Investigational Therapies (Experimental Therapy) 01/2023 - 01/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018 - 01/2017